Page 5

ewgn-vol21-issue2-v12_final

5 WORLD GASTROENTEROLOGY NEWS JULY 2016 Editorial | Expert Point of View | Gastro 2016: EGHS-WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events 5. Wranke A, Heidrich B, Ernst S, Calle Serrano B, Caruntu FA, et al. Anti-HDV IgM as a marker of disease activity in hepatitis delta. PLoS One 2014;9(7):e101002 014 Nov;21(11):e154-63. 6. Abbas Z1, Khan MA, Salih M, Jafri W. Interferon alpha for chronic hepatitis D. Cochrane Database Syst Rev 2011 Dec 7;(12):CD006002. 7. Abbas Z, Memon MS, Mithani H, Jafri W, Hamid S. Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience. Antivir Ther 2014;19:463-8. 8. Heidrich B, Yurdaydın C, Kaba-çam G, Ratsch BA, Zachou K, et al; HIDIT-1. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology 2014;60:87-97. 9. Wranke A, Serrano BC, Heidrich B, Kirschner J, Bremer B, et al, Does antiviral treatment affect the clinical long-term outcome of hepatitis delta? J Hepatol 2016;64: S163. 10. Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, et al. Oral pre-nylation inhibition with lonafarn-ib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Lancet Infect Dis 2015;15:1167-74. 11. Blank A, Markert C, Hohmann N, Carls A, Mikus G, et al. First-in- human application of the first-in- class hepatitis B and hepatitis D virus entry inhibitor myrcludex B. J Hepatol 2016 Apr 27. pii: S0168-8278(16)30145-3. 12. Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, et al. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B - first results of a Phase Ib/IIa study. J Hepatol 2016 Apr 27. pii: S0168- 8278(16)30148-9. 13. Bazinet M, Pantea V, Cebotarescu V, Cojuhari L, Jimbei P, et al. Update on the safety and efficacy of REP 2139 monotherapy and subsequent combination therapy with pegylated interferon alpha-2a in caucasian patients with chronic HBV/HDV co-infection J Hepatol 2016;64:S584.


ewgn-vol21-issue2-v12_final
To see the actual publication please follow the link above